{"log_id": 7809743694182346766, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.00439, "average": 0.985057, "min": 0.591896}, "location": {"width": 790, "top": 218, "height": 33, "left": 265}, "words": "柳氮磺吡啶的体内实验表明,口服给药时该母体药物的绝对生物利用度少于15%。口服柳"}, {"probability": {"variance": 0.005704, "average": 0.982865, "min": 0.523367}, "location": {"width": 814, "top": 251, "height": 28, "left": 229}, "words": "氮磺吡啶后,在肠道内经肠道菌群的作用代谢产生磺胺嘧啶和5-氨基水杨酸。这两种代谢产"}, {"probability": {"variance": 0.002915, "average": 0.982752, "min": 0.726973}, "location": {"width": 822, "top": 281, "height": 32, "left": 229}, "words": "物中,磺胺嘧啶在肠道内的吸收较好,代谢效率较高,而5-氨基水杨酸在肠道的吸收效果则"}, {"probability": {"variance": 2.9e-05, "average": 0.994841, "min": 0.986571}, "location": {"width": 83, "top": 314, "height": 24, "left": 229}, "words": "相差甚远"}, {"probability": {"variance": 0.002337, "average": 0.986319, "min": 0.689573}, "location": {"width": 825, "top": 364, "height": 35, "left": 225}, "words": "吸收:据文献报告,9名健康男性口服柳氮磺吡啶1克后,作为母体药物被吸收的剂量少于给"}, {"probability": {"variance": 0.003712, "average": 0.979955, "min": 0.709318}, "location": {"width": 823, "top": 392, "height": 36, "left": 227}, "words": "药剂量的15%。服药90分钟内在健康受试者的血清中检测柳氮磺吡啶浓度,其最大浓度出现"}, {"probability": {"variance": 0.00032, "average": 0.991718, "min": 0.906168}, "location": {"width": 823, "top": 421, "height": 33, "left": 226}, "words": "在服药3~12小时期间,平均峰值浓度(6μg/mL)出现在服药6小时后。相比之下,血浆中"}, {"probability": {"variance": 0.000732, "average": 0.99171, "min": 0.827095}, "location": {"width": 823, "top": 449, "height": 30, "left": 226}, "words": "磺胺嘧啶和5-氨基水杨酸的峰值浓度在给药约10小时后才出现。这一时间的延长表明通过胃"}, {"probability": {"variance": 2.5e-05, "average": 0.998046, "min": 0.974061}, "location": {"width": 825, "top": 477, "height": 32, "left": 224}, "words": "肠传输,这两种代谢产物被运送至小肠下段,在肠道菌群的参与下进行代谢。磺胺嘧啶在结"}, {"probability": {"variance": 0.001259, "average": 0.989237, "min": 0.797688}, "location": {"width": 824, "top": 503, "height": 33, "left": 224}, "words": "肠能较好地吸收,估计生物利用度为60%。在同一实验中,5-氨基水杨酸在胃肠道的吸收则"}, {"probability": {"variance": 1.3e-05, "average": 0.99757, "min": 0.983491}, "location": {"width": 378, "top": 531, "height": 31, "left": 225}, "words": "相对较差,估计生物利用度为10%至30%"}, {"probability": {"variance": 0.004156, "average": 0.975951, "min": 0.625753}, "location": {"width": 823, "top": 584, "height": 34, "left": 223}, "words": "分布:通过静脉注射计算出柳氮磺吡啶的分布体积(Vds)为7.5±1.6升。柳氮磺吡啶与白"}, {"probability": {"variance": 0.008995, "average": 0.972707, "min": 0.51033}, "location": {"width": 825, "top": 612, "height": 34, "left": 222}, "words": "蛋白的结合度非常高(>99.3%),而磺胺嘧啶与白蛋白的结合度仅约70%。磺胺嘧啶的主要代"}, {"probability": {"variance": 0.007013, "average": 0.977545, "min": 0.551032}, "location": {"width": 517, "top": 642, "height": 26, "left": 223}, "words": "谢产物乙酰磺胺嘧啶(ACSP)与血浆蛋白的结合率约90%"}, {"probability": {"variance": 0.008396, "average": 0.969451, "min": 0.578597}, "location": {"width": 823, "top": 692, "height": 32, "left": 222}, "words": "代谢:如上所述,柳氮磺吡啶在肠道菌群的作用下代谢产物为5-氨基水杨酸及磺胺嘧啶。给"}, {"probability": {"variance": 0.003715, "average": 0.989134, "min": 0.599125}, "location": {"width": 815, "top": 720, "height": 30, "left": 220}, "words": "药剂量的约15%以母体药物的形式被吸收,大部分于肝脏内代谢成5-氨基水杨酸及磺胺嘧啶"}, {"probability": {"variance": 0.001171, "average": 0.989726, "min": 0.816776}, "location": {"width": 824, "top": 748, "height": 32, "left": 219}, "words": "经检测,静脉注射的柳氮胺吡啶的血浆半衰期为7.6±3.4小时。磺胺嘧啶的主要代谢途径是"}, {"probability": {"variance": 0.0001, "average": 0.996078, "min": 0.939261}, "location": {"width": 824, "top": 774, "height": 34, "left": 218}, "words": "通过乙酰化形成乙酰磺胺嘧啶。磺胺嘧啶转变为乙酰磺胺嘧啶的代谢率取决于乙酰化代谢表"}, {"probability": {"variance": 0.000382, "average": 0.992804, "min": 0.878178}, "location": {"width": 825, "top": 802, "height": 35, "left": 218}, "words": "型。在快乙酰化表型个体中,磺胺嘧啶的平均血浆半衰期为10.4小时,在慢酰化表型个"}, {"probability": {"variance": 0.014933, "average": 0.954267, "min": 0.460359}, "location": {"width": 824, "top": 828, "height": 37, "left": 219}, "words": "体中,平均血浆半衰期为14.8小时。磺胺嘧啶也可代谢转变为5羟基磺胺嘧啶(SPOH)和"}, {"probability": {"variance": 0.001967, "average": 0.981665, "min": 0.793787}, "location": {"width": 825, "top": 858, "height": 34, "left": 218}, "words": "N乙酰基-5-羟基磺胺嘧啶。5-氨基水杨酸主要在肝脏和肠道内通过依赖于非乙酰化表型的代"}, {"probability": {"variance": 0.005427, "average": 0.971637, "min": 0.709384}, "location": {"width": 823, "top": 888, "height": 30, "left": 218}, "words": "谢途径转变为N乙酰基5对氨水杨酸。由于口服给药后5-氨基水杨酸使得血浆浓度偏低,因"}, {"probability": {"variance": 0.001447, "average": 0.981757, "min": 0.866067}, "location": {"width": 270, "top": 915, "height": 27, "left": 219}, "words": "而无法准确估算其血浆半衰期"}, {"probability": {"variance": 0, "average": 0.826333, "min": 0.826333}, "location": {"width": 26, "top": 922, "height": 25, "left": 921}, "words": "人"}, {"probability": {"variance": 0.000434, "average": 0.992235, "min": 0.871692}, "location": {"width": 824, "top": 966, "height": 29, "left": 217}, "words": "排泄:吸收的磺胺嘧啶和5氨基水杨酸及其代谢产物主要通过尿液以游离代谢产物或葡糖苷"}, {"probability": {"variance": 0.003937, "average": 0.967741, "min": 0.705622}, "location": {"width": 826, "top": 994, "height": 31, "left": 215}, "words": "酸结合物的形式排出体外。大部分5氨基水杨酸留存在结肠内,以氨基水酸和乙酰基-5"}, {"probability": {"variance": 0.000574, "average": 0.99221, "min": 0.865431}, "location": {"width": 826, "top": 1022, "height": 31, "left": 214}, "words": "氨基水杨酸的形式与排泄物共同排出体外。静脉给药后计算出柳氮磺吡啶的清除率为1升/小"}, {"probability": {"variance": 5.1e-05, "average": 0.995326, "min": 0.973851}, "location": {"width": 428, "top": 1050, "height": 28, "left": 214}, "words": "时。据估计,肾脏中的清除率占总清除率的37%"}, {"probability": {"variance": 8e-06, "average": 0.997669, "min": 0.993126}, "location": {"width": 84, "top": 1078, "height": 24, "left": 215}, "words": "特殊人群"}, {"probability": {"variance": 0.000112, "average": 0.99576, "min": 0.93778}, "location": {"width": 827, "top": 1102, "height": 36, "left": 214}, "words": "老年人:在患类风湿性关节炎的老年患者体中,柳氮磺吡啶、磺胺嘧啶及其代谢产物的血浆"}, {"probability": {"variance": 3e-05, "average": 0.9963, "min": 0.979459}, "location": {"width": 355, "top": 1132, "height": 28, "left": 213}, "words": "半衰期都会延长。其临床影响尚不清楚"}, {"probability": {"variance": 0.000284, "average": 0.994763, "min": 0.907028}, "location": {"width": 806, "top": 1161, "height": 29, "left": 214}, "words": "儿童:有文献报道一些小型研究以4岁以上的溃疡性结肠炎或炎症性肠病患儿为研究对象"}, {"probability": {"variance": 7.9e-05, "average": 0.995875, "min": 0.954149}, "location": {"width": 827, "top": 1189, "height": 30, "left": 213}, "words": "相对成人而言,这些患儿体内的柳氮磺吡啶和磺胺嘧啶的药代动力学与年龄或剂量的关系不"}, {"probability": {"variance": 4.5e-05, "average": 0.997574, "min": 0.960649}, "location": {"width": 828, "top": 1215, "height": 33, "left": 212}, "words": "密切。药代动力学比较实验可用于判断类风湿性关节炎的儿童、青少年患者和成人患者间是"}, {"probability": {"variance": 7e-06, "average": 0.9978, "min": 0.98879}, "location": {"width": 618, "top": 1244, "height": 30, "left": 213}, "words": "否存在明显的药代动力学差别,但到目前为止还没有进行过相关实验"}, {"probability": {"variance": 4e-06, "average": 0.998388, "min": 0.991761}, "location": {"width": 824, "top": 1271, "height": 33, "left": 214}, "words": "乙酰化代谢表型:磺胺嘧啶经多态性酶催化代谢为乙酰磺胺嘧啶,因此存在两类截然不同的"}, {"probability": {"variance": 4e-05, "average": 0.99682, "min": 0.967044}, "location": {"width": 825, "top": 1299, "height": 34, "left": 212}, "words": "人群:慢代谢者和快代谢者。约有60%的高加索人属于慢乙酰化代谢表型人群。与快乙酰化"}, {"probability": {"variance": 0.003256, "average": 0.983993, "min": 0.709544}, "location": {"width": 824, "top": 1328, "height": 32, "left": 213}, "words": "代谢表型人群相比,慢乙酰化代谢表型人群的磺胺嘧啶血浆半衰期较长(从10.4小时延长到"}, {"probability": {"variance": 0.001255, "average": 0.987918, "min": 0.806744}, "location": {"width": 822, "top": 1358, "height": 29, "left": 215}, "words": "1.8小时),磺胺嘧啶血浆浓度较高。其临床意义尚不清楚;不过在一项小型的药代动力学实"}, {"probability": {"variance": 0.000312, "average": 0.994202, "min": 0.890576}, "location": {"width": 809, "top": 1387, "height": 28, "left": 210}, "words": "验中,已知受试者的乙酰化代谢表型,发现在那些属磺胺嘧啶的慢乙酰化代谢表型人群中"}, {"probability": {"variance": 1e-06, "average": 0.998854, "min": 0.997793}, "location": {"width": 208, "top": 1415, "height": 25, "left": 210}, "words": "不良事件的发生率较高"}, {"probability": {"variance": 0.048898, "average": 0.70254, "min": 0.481412}, "location": {"width": 128, "top": 1401, "height": 54, "left": 975}, "words": "病药"}, {"probability": {"variance": 3.2e-05, "average": 0.997691, "min": 0.966165}, "location": {"width": 819, "top": 1443, "height": 28, "left": 209}, "words": "性别:性别对柳氮磺吡啶的代谢产物5氨基水杨酸或磺胺嘧啶的代谢率及代谢类型没有影响"}, {"probability": {"variance": 5.4e-05, "average": 0.996311, "min": 0.974573}, "location": {"width": 232, "top": 1474, "height": 24, "left": 216}, "words": "【贮藏】遮光,密封保存"}, {"probability": {"variance": 0.000242, "average": 0.993456, "min": 0.937423}, "location": {"width": 784, "top": 1504, "height": 31, "left": 215}, "words": "【包装】药用聚乙烯塑料瓶包装,每瓶装100片或60片;药用铝塑包装,每盒装60片"}, {"probability": {"variance": 0.000492, "average": 0.990396, "min": 0.928316}, "location": {"width": 165, "top": 1536, "height": 24, "left": 215}, "words": "【有效期】24个月"}, {"probability": {"variance": 3.7e-05, "average": 0.996979, "min": 0.973844}, "location": {"width": 336, "top": 1566, "height": 25, "left": 215}, "words": "【执行标准】中国药典2010年版二部"}, {"probability": {"variance": 0.002109, "average": 0.985171, "min": 0.791249}, "location": {"width": 301, "top": 1598, "height": 26, "left": 214}, "words": "【批准文号】国药准字H31020557"}], "language": 3}